VIRUSES AND CANCER. Michael Lea

Similar documents
Mutations: 2 general ways to alter DNA. Mutations. What is a mutation? Mutations are rare. Changes in a single DNA base. Change a single DNA base

Cancer can occur at almost any organ in the body

Compiled and/or written by Amy B. Vento and David R. Gillum

Viruses. Viral components: Capsid. Chapter 10: Viruses. Viral components: Nucleic Acid. Viral components: Envelope

Retroviruses May 14 th 2015

Structure and Function of DNA

7.012 Quiz 3 practice

Various Viral Vectors Necessary for Gene Therapy Delivery Systems. Abstract

Guidance. 2. Definitions. 1. Introduction

C:\Documents and Settings\George H. Timm\My Documents\Microbiology Sept 08\Micro 260 Notes\Chapter 13 Virus\How do viruses differ.

Biotechnology and Recombinant DNA (Chapter 9) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College

Fulfilling the Promise

Lecture 13: DNA Technology. DNA Sequencing. DNA Sequencing Genetic Markers - RFLPs polymerase chain reaction (PCR) products of biotechnology

Transfection-Transfer of non-viral genetic material into eukaryotic cells. Infection/ Transduction- Transfer of viral genetic material into cells.

2.1.2 Characterization of antiviral effect of cytokine expression on HBV replication in transduced mouse hepatocytes line

Viral Replication. Viral Replication: Basic Concepts

Guidance for Working with Adeno-Associated Virus (AAV) Vectors

Liver Disease and Therapy of Hepatitis B Virus Infections

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.

Prospects for Vaccines against Hepatitis C Viruses. T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS

Tumor Viruses. Chapter 3

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press

4.1 3T12 and 312 are immortalized cell lines with transforming potential:

When B Cells Go Bad: Infection, Inflammation and Chronic B Cell Stimulation

Genetics Lecture Notes Lectures 1 2

What is HIV? What is AIDS? The HIV pandemic HIV transmission Window period Stages of HIV infection

The Biological Basis of Cancer. Annie Young, Professor of Nursing, University of Warwick, University Hospitals Coventry and Warwickshire

CIBMTR Infection Data and the New Infection Inserts.

Types of Cancers [-oma growth ]!

2011 Update on the ECIL-3 guidelines for EBV management in patients with leukemia and other hematological disorders

MUTATION, DNA REPAIR AND CANCER

Recombinant DNA and Biotechnology

Cytomegalovirus (HHV5/CMV) Roseolovirus (HHV6 & 7)

What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:

Lymphomas after organ transplantation

Recombinant DNA & Genetic Engineering. Tools for Genetic Manipulation

Principles of Vaccination

CCR Biology - Chapter 9 Practice Test - Summer 2012

Vectors of Gene Therapy

Viral Infection: Receptors

Lesson 3 Reading Material: Oncogenes and Tumor Suppressor Genes

Lecture Series 7. From DNA to Protein. Genotype to Phenotype. Reading Assignments. A. Genes and the Synthesis of Polypeptides

Lymphoma Diagnosis and Classification

Why use passive immunity?

Bureau of Laboratory Quality Standards Page 1 of 6

Viral Antigens/Virale Antigene. SARS Proteins/SARS Proteine

Chapter 1 Summary basic cause of acquired immunodeficiency several years, it is too soon to tell what percent- syndrome

Principles of Vaccination

PART 3.3: MicroRNA and Cancer


About Our Products. Blood Products. Purified Infectious/Inactivated Agents. Native & Recombinant Viral Proteins. DNA Controls and Primers for PCR

New Hampshire Childhood Cancer

Leukemia Research Foundation Scientific Research Grant Recipients

Micro RNAs: potentielle Biomarker für das. Blutspenderscreening

BioBoot Camp Genetics

Co-pay assistance organizations offering assistance

Human Papillomavirus Infection and Oropharyngeal Cancer

Disclosure. Gene Therapy. Transfer of genes into cells Expression of transferred genes

FDA Briefing Document Vaccines and Related Biological Products Advisory Committee Meeting September 19, 2012

Biotechnology: DNA Technology & Genomics

Epstein Barr Virus (EBV) Serological Diagnosis of Epstein Barr Virus. Epstein Barr Virus (EBV) Epstein Barr Virus (EBV)

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor

Molecular Diagnosis of Hepatitis B and Hepatitis D infections

Appendix E-- The CDC s Current and Proposed Classification System for HIV Infection

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

2013 W. H. Freeman and Company. 26 RNA Metabolism

Interference with p53 functions in human viral infections, a target

Name Class Date. Figure Which nucleotide in Figure 13 1 indicates the nucleic acid above is RNA? a. uracil c. cytosine b. guanine d.

CASL Symposium Hepatitis B Co-chairs: Carla Coffin and Mang Ma

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Review Article

Viruses and micrornas

Hepatitis C Vaccines: Are we making progress?

Non-Hodgkin Lymphoma

Special report. Chronic Lymphocytic Leukemia (CLL) Genomic Biology 3020 April 20, 2006

The world of non-coding RNA. Espen Enerly

Publikationsliste Claudia Götz

CHAPTER 6: RECOMBINANT DNA TECHNOLOGY YEAR III PHARM.D DR. V. CHITRA

HiPer RT-PCR Teaching Kit

BIOLOGY REDISCOVERING. Cell Biology and Cancer. Molecular to Global Perspectives. Introduction

Chapter 36. Media Directory. Characteristics of Viruses. Primitive Structure of Viruses. Therapy for Viral Infections. Drugs for Viral Infections

Forensic DNA Testing Terminology

Pediatric Oncology for Otolaryngologists

Lecture 3: Mutations

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle

This module consists of four units which will provide the user a basic knowledge of cancer as a disease.

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015

Chapter 5: Organization and Expression of Immunoglobulin Genes

FIGHTING AIDS AT THE GATE

Cancer Gene Therapy: Challenges and Opportunities

Stem Cell Quick Guide: Stem Cell Basics

Final Review. Aptamers. Making Aptamers: SELEX 6/3/2011. sirna and mirna. Central Dogma. RNAi: A translation regulation mechanism.

What is cancer? Cancer. Properties of cancer cells. Properties of cancer cells. Cancer continued; three cancer types. When good cells go bad

Bottle-neck Problems of Current Human Cancer Therapy

A Genetic Analysis of Rheumatoid Arthritis

Hepatitis C Monitoring and Complications (and Treatment!) Dr Mark Douglas

CANCER EXPLAINED. Union for International Cancer Control Union Internationale Contre le Cancer

Basic Concepts Recombinant DNA Use with Chapter 13, Section 13.2

Diagnosis and Treatment of Common Oral Lesions Causing Pain

MULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist

Transcription:

VIRUSES AND CANCER 2012 Michael Lea

VIRAL ONCOLOGY - LECTURE OUTLINE 1. Historical Review 2. Viruses Associated with Cancer 3. RNA Tumor Viruses 4. DNA Tumor Viruses

HISTORICAL REVIEW Historical Review 1908 Ellerman and Bang : Leukemia induced in chickens by a cell- free extract (avian leukemia virus). 1911 Rous : Sarcoma induced in chickens by a cell-free tumor filtrate (Rous sarcoma virus). 1933 Shope : Papilloma virus from wild rabbits caused invasive tumors in domestic rabbits from which virus could be isolated. 1936 Bittner : Mammary tumors in mice caused by a factor in milk. 1951 Gross : Cell-free filtrates from AKR mice with leukemia caused leukemia in C3H mice. 1958 Stewart: t Polyoma virus; as many as 10 different tumor types could be induced in a single mouse. 1970 Baltimore; Temin and Mizutani : Reverse transcriptase (RNA-dependent DNA polymerase) associated with RNA tumor viruses.

Rous s protocol for inducing sarcomas in chickens

Retrovirus structure and typical genome

Normal Chicken Embryo Fibroblasts Transformed by RSV

A focus of chicken embryo fibroblasts transformed by RSV

ONCOGENIC VIRUSES Oncogenic RNA Viruses Oncogenic DNA Viruses Retroviruses Papovaviruses Sarcoma viruses SV40 Mammary tumor virus Polyoma virus Leukosis viruses Shope papilloma virus Human T cell leukemia viruses Human papilloma viruses Herpes viruses Hepatitis C virus Epstein-Barr (EBV) Marek's disease virus (MDV) Herpes simplex viruses (HSV) Adenoviruses Hepadnaviruses Hepatitis B virus Pox viruses Shope fibroma virus

VIRUSES ASSOCIATED WITH HUMAN CANCER HBV and HCV: Liver cancer EBV: Burkitt lymphoma EBV: Nasopharyngeal carcinoma HTLV I: Adult T-cell leukemia HTLV II: Hairy T-cell leukemia HPV 16: Cervical cancer HIV: Non-Hodgkin's lymphoma KSHV (HHV-8): Kaposi's sarcoma

VIRUS ASSOCIATED WITH SOME HUMAN PROSTATE CANCER A retrovirus called XMRV (xenotropic murine leukemia virus-related virus) was detected in 40% of prostate tumors from men who were homozygous for an allelic variant of the RNASEL gene and in only 2% of tumors from men of other genotypes. The gene codes for RNase L, a ribonuclease required for the response to interferon. Activity is impaired in the allelic variant. Reference: Dong et al., Proc. Nat. Acad. Sci. USA 104, 1655 (2007)

EPSTEIN-BARR VIRUS Epstein-Barr virus was discovered by examining electron micrographs of cells cultured from Burkitt s lymphoma, a childhood tumor that is common in areas of sub-saharan Africa where malaria is endemic. EBV is implicated in the etiology of several different lymphoid and epithelial malignancies including nasopharyngeal cancer. Immunosuppressed transplant patients are at risk of developing EBV-transformed B-cell proliferation presenting as post-transplant transplant lymphomas. EBV-infected cells express a group of nuclear proteins that influence both viral and cellular transcription. Reference: L.S. Young and A.B. Rickinson. Epstein-Barr virus: 40 years on. Nature Reviews Cancer 4: 757-768, 2004.

RNA TUMOR VIRUSES These viruses have RNA as the genetic material. In order to transform cells RNA viruses must be integrated into the host cell genome. A DNA copy is integrated after reverse transcription. These viruses do not normally kill the host cell. Not all retroviruses cause cancer. The enzyme reverse transcriptase catalyzes the production of a complementary DNA from the RNA genome and then catalyzes the formation of double stranded DNA from the single strand copy. The double stranded DNA is integrated into the host genome. Transformation can occur without viral replication which must be achieved using host mechanisms and may require a helper virus if the transforming virus is defective.

RNA TUMOR VIRUSES The avian leukosis virus has the following genetic sequence: LTR -- gag -- pol -- env -- LTR in which the long terminal repeats (LTRs) have a promoting activity for transcription and may also facilitate viral integration. The gag and env genes code for viral structural t proteins and the pol gene codes for reverse transcriptase.

RNA TUMOR VIRUSES In the Rous sarcoma virus there is a transforming gene (src) between the env gene and the 3' LTR. Other transforming retroviruses may have one of the gag, g, pol or env genes replaced by a transforming gene known as an onc gene. HTLV 1 has a gene known as the trans activating gene (tat) which can cause transcriptional activation of the virus and might activate cellular proto-oncogenes. There is a similar il gene in the human immunodeficiency virus (HIV).

DNA TUMOR VIRUSES The DNA viruses need not be incorporated into the host genome in order to replicate. In the case of hepatitis B virus in woodchucks there appears to be random integration into the host genome which may not be a prerequisite for transformation and can occur in normal cells of chronic virus carriers. On the other hand, transformation by DNA viruses is usually accompanied by integration of viral DNA into the genome of the host cell. DNA viruses tend to kill host cells.

DNA TUMOR VIRUSES The papovaviruses have a circular genome. The transforming region of the polyoma virus codes for three proteins (large, middle and small T antigens). The large T antigen elicits indefinite growth and diminishes the requirement for growth factors in serum. The middle T antigen is necessary for the maintenance of transformation. The small T-antigen protein is able to activate several cellular pathways which stimulate cell proliferation. Such as the mitogen-activated protein kinase (MAPK) pathway, and the stress-activated protein kinase (SAPK) pathway.

DNA TUMOR VIRUSES The SV40 virus has two T antigens (large and small). The large T antigen of SV40 combines the functions of the large and middle T antigens of polyoma virus. The large T antigen of SV40 can bind a host nuclear protein known as p53. This represents the inactivation of a tumor suppressor protein.

DNA TUMOR VIRUSES Herpes viruses have a linear double stranded DNA genome of 130-250 kb which could code for 100-200 proteins. Adenoviruses cause a number of diseases in humans but historically were believed not to produce tumors in man. Leukemia has been seen is some patients receiving adenoviral vectors for gene therapy. Transformation of cells by adenoviruses requires the combined action of two domains known as E1A and E1B. Each of these regions codes for two proteins. The E1A products cause indefinite growth of host cells and are proteins with a nuclear location like the large T antigens of polyoma and SV40.

SUGGESTED READING 1. Weinberg, R. The Biology of Cancer, Chapter 3, Garland Science, 2007 2. Gallo, R.C. and Reitz, M.S. RNA Tumor viruses. In: Hong et al (eds.) Holland-Frei Cancer Medicine (8th edition) Part II Scientific Foundations, Section 3 - Cancer Etiology, Chapter 20. (2010). 3. Cohen, J.I. Herpesviruses in Hong et al (eds.) Holland-Frei Cancer Medicine (8th edition) Part II Scientific Foundations, Section 3 - Cancer Etiology, Chapter 21 (2010). 4. Crum, C.P. and Chang, M.C. Papillomaviruses and Cervical Neoplasia in Hong et al (eds.) Holland-Frei Cancer Medicine (8th edition) Part II Scientific Foundations, Section 3 - Cancer Etiology, Chapter 22 (2010).